Clinical Trial Update: Clinical and Molecular Biomarker Studies in RAI1 (Retinoic Acid-Induced 1) -Related Disorders

View source ↗

Summary

This clinical trial update describes ongoing studies investigating clinical and molecular biomarkers in disorders caused by RAI1 gene alterations at 17p11.2, in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Potocki-lupski Syndrome
• Smith-magenis Syndrome

Snippet

Sponsor: Baylor College of Medicine | Conditions: RAI1 Gene 17P11.2 Deletion+Duplication | Status: RECRUITING